 |
PDBsum entry 3dd2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor/RNA
|
PDB id
|
|
|
|
3dd2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains L, H:
E.C.3.4.21.5
- thrombin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Gly; activates fibrinogen to fibrin and releases fibrinopeptide A and B.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Rna
14:2504-2512
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of an RNA aptamer bound to thrombin.
|
|
S.B.Long,
M.B.Long,
R.R.White,
B.A.Sullenger.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Aptamers, an emerging class of therapeutics, are DNA or RNA molecules that are
selected to bind molecular targets that range from small organic compounds to
large proteins. All of the determined structures of aptamers in complex with
small molecule targets show that aptamers cage such ligands. In structures of
aptamers in complex with proteins that naturally bind nucleic acid, the aptamers
occupy the nucleic acid binding site and often mimic the natural interactions.
Here we present a crystal structure of an RNA aptamer bound to human thrombin, a
protein that does not naturally bind nucleic acid, at 1.9 A resolution. The
aptamer, which adheres to thrombin at the binding site for heparin, presents an
extended molecular surface that is complementary to the protein. Protein
recognition involves the stacking of single-stranded adenine bases at the core
of the tertiary fold with arginine side chains. These results exemplify how RNA
aptamers can fold into intricate conformations that allow them to interact
closely with extended surfaces on non-RNA binding proteins.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Torrent,
M.V.Nogués,
and
E.Boix
(2011).
Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
|
| |
J Mol Recognit,
24,
90.
|
 |
|
|
|
|
 |
E.N.Brody,
L.Gold,
R.M.Lawn,
J.J.Walker,
and
D.Zichi
(2010).
High-content affinity-based proteomics: unlocking protein biomarker discovery.
|
| |
Expert Rev Mol Diagn,
10,
1013-1022.
|
 |
|
|
|
|
 |
M.C.Buff,
F.Schäfer,
B.Wulffen,
J.Müller,
B.Pötzsch,
A.Heckel,
and
G.Mayer
(2010).
Dependence of aptamer activity on opposed terminal extensions: improvement of light-regulation efficiency.
|
| |
Nucleic Acids Res,
38,
2111-2118.
|
 |
|
|
|
|
 |
N.Clementi,
A.Chirkova,
B.Puffer,
R.Micura,
and
N.Polacek
(2010).
Atomic mutagenesis reveals A2660 of 23S ribosomal RNA as key to EF-G GTPase activation.
|
| |
Nat Chem Biol,
6,
344-351.
|
 |
|
|
|
|
 |
S.K.Buddai,
J.M.Layzer,
G.Lu,
C.P.Rusconi,
B.A.Sullenger,
D.M.Monroe,
and
S.Krishnaswamy
(2010).
An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.
|
| |
J Biol Chem,
285,
5212-5223.
|
 |
|
|
|
|
 |
T.J.Povsic,
B.A.Sullenger,
S.L.Zelenkofske,
C.P.Rusconi,
and
R.C.Becker
(2010).
Translating nucleic acid aptamers to antithrombotic drugs in cardiovascular medicine.
|
| |
J Cardiovasc Transl Res,
3,
704-716.
|
 |
|
|
|
|
 |
Y.Nomura,
S.Sugiyama,
T.Sakamoto,
S.Miyakawa,
H.Adachi,
K.Takano,
S.Murakami,
T.Inoue,
Y.Mori,
Y.Nakamura,
and
H.Matsumura
(2010).
Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.
|
| |
Nucleic Acids Res,
38,
7822-7829.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.S.Petrera,
A.R.Stafford,
B.A.Leslie,
C.A.Kretz,
J.C.Fredenburgh,
and
J.I.Weitz
(2009).
Long range communication between exosites 1 and 2 modulates thrombin function.
|
| |
J Biol Chem,
284,
25620-25629.
|
 |
|
|
|
|
 |
R.H.Huang,
D.H.Fremont,
J.L.Diener,
R.G.Schaub,
and
J.E.Sadler
(2009).
A structural explanation for the antithrombotic activity of ARC1172, a DNA aptamer that binds von Willebrand factor domain A1.
|
| |
Structure,
17,
1476-1484.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.M.Nimjee,
S.Oney,
Z.Volovyk,
K.M.Bompiani,
S.B.Long,
M.Hoffman,
and
B.A.Sullenger
(2009).
Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.
|
| |
RNA,
15,
2105-2111.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |
|